HomeIndustriesHealthcareJNJ's Focus Ahead to Ensure Future Success

JNJ's Focus Ahead to Ensure Future Success

Matt Montefusco says Johnson & Johnson's (JNJ) pharma business has performed exceptionally, but the company needs to focus more on its med-tech innovation to keep up with competition. However, it's the company's legal headwinds he believes could be its biggest challenge. Lee Brown also takes a deeper look into earnings to determine other financial headwinds that could swirl off future reports.

The Watch List

15 Oct 2024

SHARE

ON AIR
education
10:00 pm
Liz Ann Live
replay
12:00 am
Market Overtime
REPLAY
12:30 am
Market On Close
REPLAY
education
2:00 am
Your First Trade
REPLAY
education
2:30 am
Your First Trade
REPLAY
3:00 am
Fast Market
REPLAY
4:00 am
Next Gen Investing
REPLAY
5:00 am
Market Overtime
REPLAY
5:30 am
The Wrap
REPLAY
7:00 am
Market Overtime
8:00 am
Market Overtime
8:30 am
Market On Close
education
10:00 am
Your First Trade
education
10:30 am
Your First Trade
11:00 am
Fast Market
12:00 pm
Next Gen Investing
1:00 pm
The Watch List
2:00 pm
Market On Close
3:30 pm
Market Overtime
REPLAY
4:00 pm
Fast Market
REPLAY
5:00 pm
Next Gen Investing
REPLAY
6:00 pm
The Wrap
REPLAY
education
7:30 pm
Liz Ann Live
REPLAY
8:00 pm
Market Overtime
REPLAY
8:30 pm
Market On Close
REPLAY
ON AIR
education
10:00 pm
Liz Ann Live
REPLAY
10:30 pm
The Wrap
REPLAY

Schwab Network's Newsletters

Daily insights for every investor